tert-butyl N-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate | CAS:145013-05-4

We serve tert-butyl N-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate CAS:145013-05-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name:  tert-butyl N-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate
CAS.NO:145013-05-4
Molecular Formula: C11H20N2O4S
Molecular Weight: 276.35300

Synonyms:
N,N'-bis(tert-butoxycarbonyl)-thiourea
N,N'-Di-Boc-thiourea
1.3-Di-(tert-butoxycarbonyl)thiourea
DIBOC-THIOUREA
N,N'-t-butoxycarbonylthiourea
N,N'-bis(1,1-dimethylethoxycarbonyl)thiourea
N,N'-Bis-tert-butoxycarbonylthiourea
1,3-Di-Boc-thiourea
N,N'-di-(tert-butoxycarbonyl)thiourea
N,N′-Di-Boc-thiourea
N,N'-BIS-BOC-THIOUREA

Physical and Chemical Properties:
Density: 1.2±0.1 g/cm3
Boiling point: /
Melting point: 131-135ºC(lit.)
Flash point: /
Refractive index: 1.504

Specification:
Appearance: White powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Storage at 0-5ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:N,N'-Di(tert-butoxycarbonyl)thiourea is used in the preparation of bis-imidazoline diphenyl derivatives as α1-adrenoceptor antagonists.

Contact us for information like tert-butyl N-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-BIS-BOC-THIOUREA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-bis(1,1-dimethylethoxycarbonyl)thiourea Use and application,N,N’-BIS-BOC-THIOUREA technical grade,usp/ep/jp grade.


Related News: Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.5-Bromo-2-Carboxy-3-Methylpyridine manufacturer Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.O-methyl dichlorothiophosphate supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).4-Methyl-3-(trifluoromethyl)aniline vendor During the deadly SARS pandemic of the early 2000s, another traditional Chinese herbal medicine, Banlangen, made from the root of a flowering woad plant and used to treat the common cold, was sold out in many pharmacies due to a popular but clinically unproven belief that it could help prevent SARS, which is closely related to the Wuhan coronavirus.China is now dealing with another disease outbreak — this one mostly affecting animals but also potentially deadly among people.